IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIALDaniel Feldman, George Dangas, Zhongie Zhang et al.|Journal of the American College of Cardiology|2022Cited by 2
IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIALDaniel Feldman, George Dangas, Davide Cao et al.|Journal of the American College of Cardiology|2022Cited by 0